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Abstract
Background—The objectives are to examine disparities in all-cause mortality risk among HIV-
positive Latinos with injection drug use (IDU) history, and to identify individual- and 
neighborhood-level predictors.
Methods—Florida surveillance data for persons diagnosed with HIV 2000–2008 were merged 
with 2007–2011 administrative data from the American Community Survey. Hazard ratios (HR) 
were calculated using multi-level weighted Cox regression adjusting for individual and 
neighborhood (ZCTA-level) factors.
Results—Of 10,989 HIV-positive Latinos, 10.3% had IDU history. Latinos with IDU history 
were at increased mortality risk compared with Latinos without IDU history after controlling for 
Corresponding Author: Mary Jo Trepka, Robert Stempel College of Public Health and Social Work, Florida International University, 
11200 SW 8th St, AHC 5, Room 487, Miami, Florida 33199, Telephone: 1- (305) 348-7186, Fax: 1- (305) 348-4901, 
trepkam@fiu.edu. 
Conflict of interest
No conflict declared
Contributors
All authors were involved in the design of the study and interpretation of findings. LM provided and managed the dataset. DMS, MJT, 
KPF analyzed the secondary data. DMS drafted the manuscript and all authors reviewed and revised the final document. All authors 
read and approved the final manuscript for submission.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
HHS Public Access
Author manuscript
Drug Alcohol Depend. Author manuscript; available in PMC 2016 September 01.
Published in final edited form as:
Drug Alcohol Depend. 2015 September 1; 154: 243–250. doi:10.1016/j.drugalcdep.2015.07.007.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
individual and neighborhood factors (adjusted HR [aHR] 1.61, 95% confidence interval [CI] 1.43–
1.80). Factors associated with mortality for those with IDU history included: being 40–59 (aHR 
6.48, 95% CI 1.41–121.05) and ≥60 years (aHR 18.75, 95% CI 3.83–356.45) compared with 13–
19 years of age; being diagnosed with AIDS within 3 months of HIV (aHR 2.31, 95% CI 1.87–
2.86); residing in an area with ≥50% Latinos compared with <25% Latinos (aHR 1.56, 95% CI 
1.19–2.04); and residing in a rural compared with an urban area at the time of diagnosis (aHR 
1.73, 95% CI 1.06–2.70). Race and neighborhood poverty were not predictors among those with 
IDU, but were among those without.
Conclusion—HIV-positive Latinos with IDU history are at increased mortality risk and have 
unique contributing factors. Tertiary prevention strategies should target those who are older, 
diagnosed at later stages, and those who live in predominantly Latino and rural areas.
Keywords
Latinos; human immunodeficiency virus; mortality; injection drug use; neighborhood
1. INTRODUCTION
The rate per 100,000 population of new human immunodeficiency virus (HIV) diagnoses is 
more than 3 times higher for Latinos than for non-Latino whites. Similarly, the rate of death 
among Latinos with HIV is 2 times higher than for non-Latino whites with HIV (Centers for 
Disease Control and Prevention (CDC), 2014). In 2011, there were 31,254 Latinos with HIV 
attributable to injection drug use (IDU) in the United States (US; CDC, 2014). Florida is 
among the top states in number of yearly HIV diagnoses and prevalent cases attributable to 
IDU (CDC, 2014). In 2011, among HIV cases attributable to IDU in Florida, 30% of males 
and 17% of females were Latino (Florida Department of Health, 2014a).
Latinos with HIV attributable to IDU experience poor outcomes along each step of the HIV 
care continuum when compared with Latinos in other HIV risk groups (Gant et al., 2014). 
Thus, it is expected that Latinos with HIV attributable to IDU have lower one and five year 
survival rates when compared with Latinos with HIV attributable to other transmission 
modes (Espinoza et al., 2008). In 2013, among individuals with HIV in Florida, 86% were 
linked to care, 55% were retained in care, 50% were receiving antiretroviral treatment, and 
39% were virally suppressed (Florida Department of Health, 2014b). Outcomes along the 
HIV care continuum for injection drug users with HIV are partially affected by the 
availability of HIV and drug treatment programs, as well as related services in the area. 
Individuals living with HIV in Florida receive HIV services through the Acquired Immune 
Deficiency Syndrome (AIDS) Insurance Continuation Program (est. 1989), AIDS Drug 
Assistance Program (est. 1987), Ryan White HIV/AIDS Program (est. 1990), Medicaid/
Medicare, non-governmental organizations, and case management programs (Florida 
Department of Health, n.d.). Statewide substance abuse treatment in Florida is primarily 
provided by the Substance Abuse and Mental Health Program under the Florida Department 
of Children and Families (Florida Department of Children and Families, 2014).
In addition to individual-level health care-related factors, neighborhood-level (e.g., as 
measured by census tract, zip code, county, etc.) social factors have been linked to HIV and 
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drug use. HIV-positive injection drug users tend to reside in clusters and concentrate in high 
poverty areas (Martinez et al., 2014a). Living in socioeconomically disadvantaged areas is 
associated with high-risk injection drug use behavior (Buchanan et al., 2003; Genereux et 
al., 2010), HIV seroconversion (Maas et al., 2007), and low rates of drug use cessation 
among injection drug users (Genberg et al., 2011; Nandi et al., 2010). Contributing to the 
association between neighborhood disadvantage and drug use behaviors are increased 
psychological stress, decreased positive social networks, and fewer health and social support 
services (Boardman et al., 2001; Galea et al., 2003; Kirby and Toshiko, 2005). 
Neighborhood disadvantage also is associated with increased mortality risk among the 
general HIV-positive population (Hanna et al., 2008; Joy et al., 2008; McFarland et al., 
2003). However, no studies to date have examined the association between neighborhood 
socioeconomic status (SES) and mortality among HIV-positive injection drug users.
Furthermore, neighborhood-level ethnic density (i.e., neighborhood racial/ethnic 
composition) is associated with health outcomes. Studies have shown lower all-cause 
mortality among the general Latino population who reside in neighborhoods with high 
Latino density (Bécares et al., 2012). Based on current data, the protective effect appears to 
be specific to Latinos (Bécares et al., 2012). Mechanisms for the ethnic density effect 
include lower perceived racism (Bécares et al., 2009; Whitley et al., 2006), enhanced social 
support (Das-Munshi et al., 2010; Halpern and Nazroo, 2000), and increased access to 
culturally appropriate health care (Benjamins et al., 2004; Whitley et al., 2006). The 
association between ethnic density and mortality has not been examined for individuals with 
HIV or who use illicit drugs.
Literature suggests interactions between HIV, drug use, and neighborhood factors. However, 
studies have focused predominantly on non-Latino populations. Thus, our objective was to: 
(a) examine disparities in mortality risk among HIV-positive Latinos with a history of IDU 
compared with those without a history of IDU, and (b) compare individual- and 
neighborhood-level predictors of mortality for these two groups.
2. METHODS
2.1. Datasets
De-identified HIV surveillance records were obtained from the Florida Department of 
Health enhanced HIV/AIDS reporting system (eHARS). Cases of Latinos age ≥13 who met 
the Centers for Disease Control and Prevention (CDC) HIV case definition (Schneider et al., 
2008) during the years 2000–2008 were analyzed. Vital status was ascertained through 2011 
by linkage with Florida Vital Records, the Social Security Death Master File, and the 
National Death Index. Cases with missing or invalid data for ZIP code at time of HIV 
diagnosis, and cases diagnosed in a correctional facility, were excluded. The 2007–2011 
American Community Survey (ACS) was used to obtain data by ZIP code tabulation area 
(ZCTA) (ACS, 2014a). ZCTAs are ZIP code approximations used by the US Census Bureau 
to tabulate summary statistics (US Census Bureau, n.d.). Hereinafter, ZIP code/ZCTA-level 
data will be referred to as neighborhood-level data.
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2.2. Individual- and neighborhood-level variables
The following individual-level data were extracted from eHARS: ethnicity, race, HIV 
diagnosis year, sex at birth, age at HIV diagnosis, HIV transmission mode, birth country, 
HIV-to-AIDS interval in months (if case progressed to AIDS), HIV-to-death interval in 
months (if individual died by December 31, 2011), residential ZIP code at time of HIV 
diagnosis, and whether the case was diagnosed at a correctional facility. Thirteen 
neighborhood-level SES indicators were extracted from the ACS (Niyonsenga et al., 2013): 
percent of households without access to a car, percent of households with ≥1 person per 
room, percent of population living below the poverty line, percent of owner-occupied homes 
worth ≥$300,000, median household income in 2011, percent of households with annual 
income <$15,000, percent of households with annual income ≥$150,000, income disparity 
(derived from percent of households with annual income <$10,000 and percent of 
households with annual income ≥$50,000), percent of population age ≥25 with less than a 
12th grade education, percent of population age ≥25 with a graduate professional degree, 
percent of households living in rented housing, percent of population age ≥16 who were 
unemployed, and percent of population age ≥16 employed in high working class occupation. 
We additionally extracted percent of population who identified as Hispanic or Latino from 
the ACS.
Individual- and neighborhood-level data were merged by matching the ZIP code at time of 
HIV diagnosis of each case with the ZIP code’s corresponding ZCTA. Cases with IDU, or 
IDU plus MSM, listed as a mode of HIV transmission were categorized as having a history 
of IDU. Data on mode of HIV transmission were self-reported during HIV testing, reported 
by a health care provider, or extracted from medical chart reviews. Latinos were coded as 
US-born if they were born in any of the 50 states, District of Columbia, Puerto Rico, or any 
US dependent area. The 2011 ACS/US Census Bureau Hispanic origin classification was 
used to define birthplace for the Central America and South America categories (ACS, 
2014b). We defined late HIV diagnosis as an AIDS diagnosis within 3 months of HIV 
diagnosis (CDC, 2013). Income disparity was calculated as the logarithmic of 100 times the 
percent of households with annual income <$10,000 divided by the percent of households 
with annual income ≥$50,000 and was used as a proxy measure of the Gini-coefficient 
(Niyonsenga et al., 2013; Singh and Siahpush, 2002). All neighborhood-level indicators 
were coded so that higher scores meant higher poverty and were standardized (Niyonsenga 
et al., 2013). The percent of Latinos/Hispanics in a neighborhood was divided into 3 
categories: <25%, 25–49%, and ≥50% (Alvarez and Levy 2012; Shaw et al., 2010). 
Categorization C of Version 2.0 of the Rural-Urban Commuting Area (RUCA) codes, 
developed by the University of Washington WWAMI Rural Research Center (WWAMI 
Rural Health Research Center, n.d.), were used to categorize neighborhoods into rural or 
urban status.
2.3. Statistical analyses
Following the analytical methods of Niyonsenga et al. (2013), we sought to develop an SES 
index using the 13 ACS indicators. First, we conducted a reliability analysis. The 
Cronbach’s alpha for all 13 indicators was 0.9411. We selected 7 indicators based on the 
correlation of the indicator with the total index (high correlation), and the Cronbach’s alpha 
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if the item was deleted (low alpha). The 7 indicators selected were: percent below poverty, 
median household income, percent of households with annual income <$15,000, percent of 
households with annual income ≥$150,000, income disparity, percent of population age ≥25 
with less than a 12th grade education, and highclass work. The resulting Cronbach’s alpha 
increased (0.9564).
Second, we conducted a principal component analysis with and without varimax rotation, 
which revealed one factor with an eigenvalue greater than 1 (5.5632). These results are 
consistent with previous research (Krieger et al., 2003a, 2003b; Messer et al., 2006; Hogan 
and Tchernis, 2004). This factor accounted for 79.47% of the variance in the indicators. 
Because all the factor loadings were high (between 0.80 and 0.95), we retained all 7 
indicators. The selected indicators were consistent with those chosen for the urban “poverty 
index” in Niyonsenga et al. (2013). Finally, we calculated a “poverty index” score by adding 
the standardized scores for the 7 variables and categorized the scores into quartiles.
Following development of the poverty index, we compared individual- and neighborhood-
level characteristics by history of IDU. We used the Cochran-Mantel-Haenszel general 
association statistic for individual-level variables controlling for ZCTA, and the chi-square 
test for neighborhood-level variables. Third, we generated Kaplan-Meier survival curves for 
all-cause mortality by history of IDU and by neighborhood characteristics stratified by 
history of IDU. These analyses revealed a violation of the proportional hazard assumption. 
Therefore, the SAS macro PHSREG by Kohl and Heinze (2012) was used to run weighted 
Cox models. Multi-level (level 1: individual; level 2: neighborhood) modeling was used to 
account for correlation among cases living in the same neighborhood. Crude and adjusted 
hazard ratios and 95% confidence intervals were calculated comparing Latinos with history 
of IDU with those without history of IDU. To identify predictors of mortality for each 
group, separate models were estimated stratifying by history of IDU. Hazard ratios were 
adjusted for race, HIV diagnosis year, sex, age, birthplace, late diagnosis, poverty index 
(hereinafter referred to as “poverty”), neighborhood-level percent Hispanic/Latino, and 
rural/urban status. SAS software, version 9.3 (SAS Institute, Cary, NC 2002) was used to 
conduct analyses. The Florida Department of Health and Florida International University 
institutional review boards approved our study.
3. RESULTS
3.1. Participants
Of 10,989 Latinos who were 13 years of age and older and diagnosed with HIV in Florida 
between 2000 and 2008, 1,126 (10.3%) were reported as having a history of IDU (Table 1). 
Compared with Latinos without history of IDU, those with history of IDU were more likely 
to be diagnosed earlier in the epidemic (p-value <0.0001), be 40–59 years of age (p-value 
<0.0001), born in the US and Puerto Rico (p-value <0.0001), and have a survival after HIV 
diagnosis of less than 3 years (p-value <0.0001). Those with history of IDU were also more 
likely to live in an area in the highest quartile of neighborhood poverty (i.e., the poorest 
neighborhoods) (p-value <0.0029), an area with <25% Hispanics/Latinos (p-value <0.0001), 
and a rural area (p-value 0.0475).
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3.2. Individual and neighborhood predictors of mortality
The risk of all-cause mortality risk was two times greater for Latinos with history of IDU 
compared with Latinos without history of IDU (crude HR 2.00, 95% CI 1.79–2.23) (Figure 
1). The increased risk persisted after adjusting for individual- (aHR 1.64, 95% CI 1.45–1.83) 
and individual- and neighborhood-level variables together (aHR 1.61, 95% CI 1.43–1.80) 
(data not in table).
Mortality risk was higher for Latinos with history of IDU who were diagnosed in 2000–
2002 compared with Latinos diagnosed in 2006–2008 (aHR 1.47, 95% CI 1.03–2.13), 40–59 
(aHR 6.48, 95% CI 1.41–121.05) and ≥60 years of age (aHR 18.75, 95% CI 3.83–356.45) 
compared with 13–19 years of age, diagnosed late (aHR 2.31, 95% CI 1.87–2.86), and who 
lived in a rural compared with an urban area (aHR 1.73, 95% CI 1.06–2.70) (Table 2). 
Latinos with history of IDU who were of race other than black compared with white (aHR 
0.29, 95% CI 0.20–0.40), lived in the 2nd (aHR 0.44, 95% CI 0.31–0.62) and 3rd (aHR 0.72, 
95% CI 0.54–0.97) quartile of poverty compared with the 1st quartile, and in an area with 
<25% Latinos compared with ≥50% Latinos were at decreased risk of mortality (aHR 0.64, 
95% CI 0.49–0.84).
Mortality risk was higher for Latinos without history of IDU who were black compared with 
Latinos who were white race (aHR 1.63, 95% CI 1.40–1.88), diagnosed in the year 2000–
2002 compared with 2006–2008 (aHR 1.85, 95% CI 1.58–2.18), 40–59 (aHR 2.13, 95% CI 
1.42–3.36) and ≥60 years of age (aHR 5.97, 95% CI 3.92–9.58) compared with 13–19 years 
of age, and diagnosed late (aHR 2.27, 95% CI 2.06–2.50) (Table 2). Mortality risk was also 
higher for Latinos without history of IDU who lived in the 2nd (aHR 1.40, 95% CI 1.20–
1.64), 3rd (aHR 1.61, 1.39–1.87), and 4th (aHR 1.75, 95% CI 1.51–2.03) quartiles of poverty 
compared with the lowest quartile, and in an area with 25–49% Latinos compared with 
≥50% Latinos (aHR 1.29, 95% CI 1.14–1.46).
4. DISCUSSION
In our study, the adjusted mortality risk for HIV-positive Latinos with history of IDU was 
two times that of their non-IDU counterparts. Black race was not associated with mortality 
for Latinos with history of IDU but was a risk factor for Latinos without history of IDU. 
Age and late diagnosis were individual-level predictors for both groups. Neighborhood 
poverty was not consistently associated with mortality for Latinos with history of IDU, and 
appeared to be protective, but was a risk factor for mortality for Latinos without history of 
IDU. Residing in a low Latino ethnic density neighborhood decreased the mortality risk for 
Latinos with history of IDU. Finally, residing in a rural neighborhood increased the 
mortality risk for Latinos with history of IDU only.
HIV-positive Latinos with history of IDU were at increased risk of mortality compared with 
HIV-positive Latinos without history of IDU even after controlling for individual- and 
neighborhood-level factors. This is consistent with results from Espinoza et al. (2008) who 
reported lower survival rates, and with Gant et al. (2014), who reported lower proportions of 
linkage to and retention in care and viral suppression, among HIV-positive Latinos with 
history of IDU compared with Latinos without history of IDU. Our findings are inconsistent 
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with results from a study of HIV-positive individuals in a universal health care setting that 
found no disparity in mortality risk between injection drug users and non-injection drug 
users (Joy et al., 2008). However, our study differs in that our sample included only Latinos, 
and included individuals with and without access to care. While we were unable to find 
linkage to and retention in care rates for Latino injection drug users in Florida during our 
study period, a study of the general HIV-positive population showed that injection drug 
users are 2.5 times more likely to miss healthcare visits compared with those with HIV 
attributable to MSM (Horberg et al., 2013) and that adherence to HIV treatment is 
suboptimal among injection drug users (Bouhnik et al., 2002).
Race was a risk factor for mortality among Latinos without history of IDU, but not for 
Latinos with history of IDU. Race for Latinos is rarely included in studies of HIV-positive 
Latinos, often because of limited data collection methods for race and ethnicity. We were 
unable to find a study examining racial disparities in survival among HIV-positive Latinos 
to compare our results. However, our findings suggest that racial disparities in HIV/AIDS 
survival among Latinos are wider compared with racial disparities among the general HIV-
positive population (Hanna et al., 2008, Oramasionwu et al., 2009, Trepka et al., 2013b). Of 
note, being born in Cuba was a significant predictor of mortality for Latinos without history 
of IDU after controlling for all other individual- and neighborhood-level predictors except 
for race (aHR 1.16, 95% CI 1.01–1.34), and disappeared only after controlling for race (aHR 
1.04, 95% CI 0.90–1.20). Similarly, being born in Mexico was protective (aHR 0.72, 95% 
CI 0.58–0.89), but not after controlling for race (aHR 0.90, 95% CI 0.72–1.12).
Our findings suggest that age is additionally harmful for Latinos with history of IDU 
compared with Latinos without history of IDU. This effect might be biological or social in 
nature. Individuals diagnosed with HIV at older ages can experience faster disease 
progression (Langford et al., 2007; Nogueras et al., 2006). Evidence suggests that the use of 
drugs might also accelerate the progression of HIV to AIDS (Cole et al., 2015) by 
weakening the immune system, interacting with antiretroviral medication, and increasing 
social barriers to treatment access and adherence (Kapadia et al., 2005).
The relationship between neighborhood poverty and mortality differed for Latinos with and 
without history of IDU. Consistent with previous studies of the general HIV-positive 
population (Hanna et al., 2008; McFarland et al., 2003; Trepka et al., 2013b), neighborhood 
poverty was associated with increased mortality for Latinos without history of IDU. The 
effect was strong and persisted after controlling for individual and other neighborhood 
factors. However, our findings showed puzzling results for Latinos with history of IDU. 
Residing in the two middle quartiles of poverty was protective compared with the lowest 
quartile of poverty, but the effect disappeared for areas of highest poverty. The mechanisms 
through which poverty affects survival among HIV-positive Latinos (Boardman et al., 2001; 
Galea et al., 2003; Kirby and Toshiko, 2005) may not hold for Latinos with history of IDU. 
It is possible that more HIV prevention and treatment resources are allocated to higher 
poverty areas, as the injection drug using population in these areas is typically larger 
(Martinez et al., 2014a). However, the advantages of the increased targeting may not hold 
for areas in the highest quartile of poverty (Boardman et al., 2001; Galea et al., 2003; Kirby 
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and Toshiko, 2005). Small numbers of Latinos with history of IDU in the lowest quartile of 
neighborhood poverty could have limited our ability to find an association.
Residing in an area with <25% Latinos compared with ≥50% Latinos was protective for 
Latinos with history of IDU. This effect was not observed among Latinos without history of 
IDU. These findings contradict the ethnic density literature for the general Latino 
population, which suggests that higher, rather than lower, ethnic density provides health 
benefits (Eschbach et al., 2004; Inagami et al., 2006). However, past ethnic density research 
has been limited to all-cause mortality among the general Latino population. We speculate 
that high levels of HIV-related stigma in high Latino density areas are preventing HIV-
positive Latinos from utilizing the enhanced social support that leads to better health (Das-
Munshi et al., 2010; Halperin and Nazroo, 2000; Smith et al., 2008). HIV-related stigma is 
higher among Latinos compared to non-Latino whites, and among less acculturated Latinos 
compared to more acculturated Latinos (Rajabiun et al., 2008). Latinos in high Latino 
density areas in Florida have been shown to have low acculturation levels (Schwartz et al., 
2013).
Finally, our study indicates that residing in a rural compared with an urban area increases 
mortality risk for Latinos with history of IDU only. This effect was observed despite the 
relatively small number of rural residents, and the effect decreased after adjusting for 
individual-level and neighborhood-level factors. A previous study of HIV-positive 
individuals in Florida indicated no survival disparity between rural and urban residents 
(Trepka et al., 2013a), consistent with our findings for Latinos without history of IDU. Our 
finding for Latinos with history of IDU might have differed because the previous study 
examined individuals with AIDS of all races/ethnicities across all HIV-risk groups. The 
small number of rural cases did not allow us to perform subanalyses to identify associated 
factors. However, a study of 2,222 injection drug users and crack users in Florida found that 
urban participants were 2.57 times more likely to report utilizing drug treatment compared 
with their rural counterparts (Metsch and McCoy, 1999). Furthermore, only 4.8% of Latino 
rural participants reported ever being in drug treatment. Poor access to drug treatment—
coupled with limited availability of HIV-related resources (Sutton et al., 2010), heightened 
IDU- and HIV-related stigma, and decreased confidentiality in rural and low HIV 
prevalence areas—may explain rural/urban mortality disparities among Latinos with history 
of IDU (Zukoski and Thorburn, 2009).
Our study has limitations. First, surveillance records provide data on history of IDU to 
describe likely mode of HIV transmission. Therefore, while we know the drug use occurred 
prior to HIV diagnosis, we had no information about current IDU. Nevertheless, it is likely 
that individuals in high-poverty neighborhoods continued to use drugs, as injection cessation 
is lowest among those who live in neighborhoods of high deprivation (Genberg et al., 2011; 
Nandi et al., 2010; Williams and Latkin, 2007). We also did not have data on history of drug 
abuse or use of non-IDU illicit or prescription drugs. Although the proportion of Latinos 
with history of IDU (10%) was consistent with previous studies (Espinoza et al., 2012), IDU 
might be underreported among Latinos (Johnson and Bowman, 2003), particularly among 
those who are foreign-born and undocumented. Second, we were limited to using ZIP codes 
to define neighborhoods. A study in San Francisco found that HIV-positive injection drug 
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users traveled within a 0.87-mile activity space daily (standard deviation [SD] 2.4 miles) and 
Latino injection drug users traveled 2.8 miles (SD 3.4) (Martinez et al., 2014b). Therefore, 
we believe most of our IDU population had the potential to be affected by ZIP code-level 
characteristics, particularly in urban ZCTAs that tend to be smaller in area than rural 
ZCTAs. Related, a high proportion of HIV-positive injection drug users have unstable 
housing (Aidala et al., 2007). We had relatively complete information on ZIP code at time of 
diagnosis but no information on ZIP code throughout the follow-up period and incomplete 
ZIP code at time of death. While this is a limitation, the fact that injection drug users appear 
to move short distances (Martinez et al., 2014b) and that ZIP codes are relatively large 
suggests that most injection drug users may remain in the same general neighborhood. A 
study of individuals who died of AIDS in Florida found that 86% of those infected by 
injection drug use did not move after HIV diagnosis (Trepka et al., 2014).
Third, researchers have suggested that less complex SES indicators (such as poverty alone) 
might be useful in comparing results across studies, populations, and geographic areas 
(Krieger et al., 2002; 2003a). Although we used a poverty index, the index was highly 
correlated to poverty alone (i.e., the percentage of the population below the poverty level)
(Pearson correlation 0.91). Results did not differ when using the poverty index vs. poverty 
alone; however, effect sizes were stronger for the poverty index. It is possible that for 
Latinos, this comprehensive measurement of poverty is better than poverty alone as it 
accounts for education and type of work—variables that might be related to differential 
access to care. It is also possible that the stronger effect size observed with the index is 
because quartiles of the poverty index are based on the distribution of scores among the 
HIV-positive population, in contrast to commonly used poverty quartiles of the general 
population. Fourth, data available through surveillance records are limited. Therefore, we 
were unable to control for variables such as individual-level socioeconomic status, health 
insurance, immigration status, or time in the US. Finally, our study examined Latinos 
diagnosed with HIV in Florida. The generalizability of the findings is therefore limited to 
this population.
Our study confirms disparities in mortality risk for Latinos with history of IDU and differing 
associated risk factors when compared with Latinos without history of IDU. Findings 
suggest that older age, late diagnosis, high Latino ethnic neighborhood density, and rural 
residence increase mortality risk for HIV-positive Latinos with history of IDU. Furthermore, 
black race and neighborhood poverty appear to be a strong predictor for mortality among 
Latinos without history of IDU, but not for Latinos with history of IDU.
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FIGURE 1. 
Survival probability curves for Latinos reported with HIV by history of injection drug use 
(IDU), Florida, 2000–2011
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TABLE 1
Characteristics of Latinos 13 years and older reported with HIV with a history of injection drug use vs. no 
history of injection drug use, Florida, 2000–2008
History of injection drug use
Yesa No
Characteristic Total, nb n (%) n (%) P-valuec
Total 10,989 1,126 (100) 9,863 (100)
Individual-level variables
Race 0.8596
 Black 792 99 (8.8) 693 (7.0)
 White 8,712 862 (76.6) 7,850 (79.6)
 Other 1,485 165 (14.7) 1,320 (13.4)
Year of HIV diagnosis <0.0001
 2000–2002 3,833 478 (42.5) 3,355 (34.0)
 2003–2005 3,669 363 (32.2) 3,306 (33.5)
 2006–2008 3,487 285 (25.3) 3,202 (32.5)
Sex at birth 0.0954
 Male 8,729 886 (78.7) 7,843 (79.5)
 Female 2,260 240 (21.3) 2,020 (20.5)
Age group at diagnosis <0.0001
 13–19 years 238 12 (1.1) 226 (2.3)
 20–39 years 5,993 516 (45.8) 5,477 (55.5)
 40–59 years 4,232 565 (50.2) 3,667 (37.2)
 60 years or older 526 33 (2.9) 493 (5.0)
US- vs. foreign-born <0.0001
 US-born d 4,396 769 (68.3) 3,627 (36.8)
 Foreign-born 6,593 357 (31.7) 6,236 (63.2)
Birthplace <0.0001
 United States 3,299 461 (40.9) 2,838 (28.8)
 Puerto Rico 1,097 308 (27.4) 789 (8.0)
 Cuba 1,772 128 (11.4) 1,644 (16.7)
 Mexico 742 49 (4.4) 693 (7.0)
 Central America e 1,017 41 (3.6) 976 (9.9)
 South America f 1,386 64 (5.7) 1,322 (13.4)
 Other g 1,676 75 (6.7) 1,601 (16.2)
Late HIV diagnosis (AIDS diagnosis within 3 months of HIV diagnosis) 0.2542
 Yes 3,519 395 (35.1) 3,124 (31.7)
 No 7,470 731 (64.9) 6,739 (68.3)
Three-year survival <0.0001
 Yes (alive) 9,918 965 (85.7) 8,953 (90.8)
 No 1,071 161 (14.3) 910 (9.2)
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History of injection drug use
Yesa No
Characteristic Total, nb n (%) n (%) P-valuec
Five-year survival <0.0001
 Yes (alive) 9,651 906 (80.5) 8,745 (88.7)
 No 1,338 220 (19.5) 1,118 (11.3)
ZCTA-level variables
Poverty index, quartilesh 0.0029
 1 (lowest poverty) 2,769 258 (22.9) 2,511 (25.5)
 2 2,741 259 (23.0) 2,482 (25.2)
 3 2,790 285 (25.3) 2,505 (25.4)
 4 (highest poverty) 2,689 324 (28.8) 2,365 (24.0)
Percent of population who self-identified as Hispanic/Latino <0.0001
 ≥50 4,111 331 (29.4) 3,780 (38.3)
 25–49 3,307 347 (30.8) 2,960 (30.0)
 <25 3,571 448 (39.8) 3,123 (31.7)
RUCA classification 0.0475
 Rural 217 31 (2.8) 186 (1.9)
 Urban 10,772 1,095 (97.3) 9,677 (98.1)
US=United States; ZCTA=ZIP code tabulation area; SES=socioeconomic status; RUCA=Rural-Urban Commuting Area. Percentages may not add 
up to 100 due to rounding.
a
Includes cases reported as both injection drug use and both male-to-male sexual contact and injection drug use.
b
Excludes cases diagnosed in a correctional facility, missing residential zip code at time of HIV diagnosis, or diagnosed under the age of 13.
c
P-value for individual-level variables from Cochran-Mantel-Haenszel test controlling for residential zip code. P-value for neighborhood-level 
variables from chi-square test.
dCategory includes cases born in any of the 50 US states, District of Columbia, or any US dependency.
e
Includes cases born in the following countries: Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, and Panama.
f
Includes cases born in the following countries: Argentina, Bolivia, Chile, Colombia, Ecuador, Paraguay, Peru, Uruguay, and Venezuela.
g
Includes cases identified as “Hispanic/Latino” and born in countries other than the United States, Puerto Rico, Mexico, Cuba, Central American 
and South America with the exception of Brazil. This category includes cases born in Brazil and the Dominican Republic.
hSES quartiles of standardized SES scores of the HIV-positive Latino population.
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TABLE 2
Weighted multilevel Cox regression hazard ratios for mortality and 95% confidence intervals for Latinos 
reported with HIV by history of injection drug use, Florida, 2000–2011
History of injection drug use
Yes No
Characteristic Crude HR (95% CI) aHR (95% CI) Crude HR (95% CI) aHR (95% CI)
Individual-level variables
Race
 Black 0.99 (0.70–1.38) 0.88 (0.54–1.14) 1.85 (1.61–2.12) 1.63 (1.40–1.88)
 White Referent Referent Referent Referent
 Other 0.37 (0.26–0.51) 0.29 (0.20–0.40) 0.14 (0.11–0.18) 0.12 (0.09–1.15)
Year of HIV diagnosis
 2000–2002 1.28 (0.90–1.85) 1.47 (1.03–2.13) 1.38 (1.18–1.62) 1.85 (1.58–2.18)
 2003–2005 1.05 (0.73–1.55) 1.07 (0.74–1.58) 1.18 (1.01–1.40) 1.13 (0.96–1.33)
 2006–2008 Referent Referent Referent Referent
Sex at birth
 Male 1.03 (0.82–1.32) 0.87 (0.68–1.12) 1.03 (0.82–1.32) 1.07 (0.95–1.21)
 Female Referent Referent Referent Referent
Age group at diagnosis
 13–19 years Referent Referent Referent Referent
 20–39 years 4.06 (0.90–75.56) 3.81 (0.83–71.09) 1.30 (0.87–2.05) 1.29 (0.87–2.04)
 40–59 years 7.32 (1.62–75.56) 6.48 (1.41–121.05) 2.43 (1.63–3.83) 2.13 (1.42–3.36)
 60 years or older 24.54 (5.16–462.79) 18.75 (3.83–356.45) 6.72 (4.44–10.73) 5.97 (3.92–9.58)
Birthplace
 United States Referent Referent Referent Referent
 Puerto Rico 1.18 (0.93–1.49) 1.06 (0.83–1.34) 1.27 (1.07–1.50) 1.09 (0.92–1.29)
 Cuba 1.43 (1.06–1.90) 0.96 (0.68–1.33) 1.52 (1.33–1.74) 1.04 (0.90–1.20)
 Mexico 0.82 (0.45–1.37) 0.72 (0.39–1.21) 0.89 (0.71–1.09) 0.90 (0.72–1.12)
 Central America 0.53 (0.23–1.03) 0.38 (0.16–0.74) 0.81 (0.67–0.98) 0.69 (0.57–0.84)
 South America 0.18 (0.07–0.40) 0.20 (0.07–0.45) 0.49 (0.40–0.59) 0.50 (0.41–0.61)
 Other 0.74 (0.46–1.14) 0.56 (0.33–0.88) 0.77 (0.66–0.89) 0.75 (0.64–0.88)
Late HIV diagnosis (AIDS diagnosis within 3 
months of HIV diagnosis)
 Yes 2.03 (1.67–2.48) 2.31 (1.87–2.86) 2.34 (2.12–2.57) 2.27 (2.06–2.50)
 No Referent Referent Referent Referent
ZCTA-level variables
Poverty index, quartiles
 1 (lowest poverty) Referent Referent Referent Referent
 2 0.48 (0.34–0.66) 0.44 (0.31–0.62) 1.32 (1.13–1.53) 1.40 (1.20–1.64)
 3 0.77 (0.58–1.02) 0.72 (0.54–0.97) 1.56 (1.35–1.81) 1.61 (1.39–1.87)
 4 (highest poverty) 1.15 (0.90–1.48) 0.92 (0.71–1.20) 2.07 (1.80–2.39) 1.75 (1.51–2.03)
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History of injection drug use
Yes No
Characteristic Crude HR (95% CI) aHR (95% CI) Crude HR (95% CI) aHR (95% CI)
Percent of population who self-identified as 
Hispanic/Latino
 ≥50 Referent Referent Referent Referent
 25–49 0.89 (0.71–1.13) 0.98 (0.76–1.27) 1.00 (0.89–1.12) 1.29 (1.14–1.46)
 <25 0.60 (0.47–0.77) 0.64 (0.49–0.84) 0.91 (0.81–1.02) 1.10 (0.96–1.25)
RUCA classification
 Rural 1.91 (1.22–2.84) 1.73 (1.06–2.70) 1.35 (0.98–1.81) 0.89 (0.64–1.20)
 Urban Referent Referent Referent Referent
HR, hazard ratio; aHR, adjusted hazard ratio; CI, confidence interval; ZCTA, zip code tabulation area; RUCA, Rural-Urban Commuting Area.
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